Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests
RIJKEN, D. C., KOCK, E. L., GUIMARÃES, A. H. C., TALENS, S., MURAD, S. DARWISH, JANSSEN, H. L. A., LEEBEEK, F. W. G.
Published in Journal of thrombosis and haemostasis (01.10.2012)
Published in Journal of thrombosis and haemostasis (01.10.2012)
Get full text
Journal Article
Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children
EMONTS, M., DE BRUIJNE, E. L. E., GUIMARÃES, A. H. C., DECLERCK, P. J., LEEBEEK, F. W. G., DE MAAT, M. P. M., RIJKEN, D. C., HAZELZET, J. A., GILS, A.
Published in Journal of thrombosis and haemostasis (01.02.2008)
Published in Journal of thrombosis and haemostasis (01.02.2008)
Get full text
Journal Article
A new functional assay of thrombin activatable fibrinolysis inhibitor
GUIMARÃES, A. H. C., BERTINA, R. M., RIJKEN, D. C.
Published in Journal of thrombosis and haemostasis (01.06.2005)
Published in Journal of thrombosis and haemostasis (01.06.2005)
Get full text
Journal Article
Migration of the activation peptide of thrombin‐activatable fibrinolysis inhibitor (TAFI) during SDS–polyacrylamide gel electrophoresis
Guimarães, A. H. C., Barrett‐Bergshoeff, M. M., Gils, A., Declerck, P. J., Rijken, D. C.
Published in Journal of thrombosis and haemostasis (01.05.2004)
Published in Journal of thrombosis and haemostasis (01.05.2004)
Get full text
Journal Article
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study
de Bruijne, E L E, Gils, A, Guimarães, A H C, Dippel, D W J, Deckers, J W, van den Meiracker, A H, Poldermans, D, Rijken, D C, Declerck, P J, de Maat, M P M, Leebeek, F W G
Published in Journal of thrombosis and haemostasis (01.06.2009)
Published in Journal of thrombosis and haemostasis (01.06.2009)
Get full text
Journal Article
High functional levels of thrombin‐activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke
LEEBEEK, F. W. G., GOOR, M. P. J., GUIMARAES, A. H. C., BROUWERS, G.‐J., MAAT, M. P. M., DIPPEL, D. W. J., RIJKEN, D. C.
Published in Journal of thrombosis and haemostasis (01.10.2005)
Published in Journal of thrombosis and haemostasis (01.10.2005)
Get full text
Journal Article
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children
Emonts, M, de Bruijne, E L E, Guimarães, A H C, Declerck, P J, Leebeek, F W G, de Maat, M P M, Rijken, D C, Hazelzet, J A, Gils, A
Published in Journal of thrombosis and haemostasis (01.02.2008)
Published in Journal of thrombosis and haemostasis (01.02.2008)
Get full text
Journal Article
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study1
DE BRUIJNE, E. L. E., GILS, A., GUIMARÃES, A. H. C., DIPPEL, D. W. J., DECKERS, J. W., VAN DEN MEIRACKER, A. H., POLDERMANS, D., RIJKEN, D. C., DECLERCK, P. J., DE MAAT, M. P. M., LEEBEEK, F. W. G.
Published in Journal of thrombosis and haemostasis (01.06.2009)
Published in Journal of thrombosis and haemostasis (01.06.2009)
Get full text
Journal Article